Verona Pharma Cash from Financing (TTM) Insights

Verona Pharma PLC (VRNA)

15.47 +0.16 (+1.05%) USD | NASDAQ | Apr 26, 16:00

15.50 +0.03 (+0.19%) Pre-Market: 20:00

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2017. Upgrade now.

Date	Value
December 31, 2023	92.87M
September 30, 2023	71.47M
June 30, 2023	211.04M
March 31, 2023	210.23M
December 31, 2022	140.82M
September 30, 2022	137.30M
June 30, 2022	-4.133M
March 31, 2022	-6.843M
December 31, 2021	-6.117M
September 30, 2021	-1.266M
June 30, 2021	188.94M
March 31, 2021	192.34M
December 31, 2020	192.34M

Date	Value
September 30, 2020	188.76M
June 30, 2020	0.2129M
March 31, 2020	0.1096M
December 31, 2019	0.00
September 30, 2019	-0.372M
June 30, 2019	-0.2129M
March 31, 2019	-0.1096M
December 31, 2018	0.00
September 30, 2018	0.742M
June 30, 2018	2.820M
March 31, 2018	86.79M
December 31, 2017	85.47M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

-6.843M

Minimum

Mar 2022

211.04M

Maximum

Jun 2023

84.61M

Average

71.47M

Median

Sep 2023

Cash from Financing (TTM) Benchmarks